概括
针对心力衰竭与减少喷射率 (HFrEF) 的指导导向医学疗法 (GDMT) 显著减少了住院和死亡率. 提高这种四重疗法的利用率对于更好的患者结果至关重要.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 减少喷射分数 (HFrEF) 的心力衰竭是致病率,死亡率和公共卫生负担的重要原因.
- 最近的进展已经引入了指南导向医学治疗 (GDMT) 作为HFrEF的基石治疗.
研究的目的:
- 总结一下HFrEF的GDMT的当前状态.
- 突出四重治疗的组成部分及其益处.
- 解决GDMT的不足利用问题,并建议改进的领域.
主要方法:
- 关于HFrEF处理的最新科学文献的综述.
- 分析指南导向医学治疗 (GDMT) 的组成部分.
- 对HFrEF药物的新启动和定位协议进行讨论.
主要成果:
- 四重疗法,包括 ангиотензин受体-尼普利辛抑制剂 (ARNI),β-阻断剂 (BB),矿物质皮质体受体对抗剂 (MRA) 和-葡萄糖转移体-2 抑制剂 (SGLT-2i),显著降低了HF住院,全因死亡率和心血管死亡率.
- 启动和定位GDMT的新协议可能会改善HFrEF管理和预后.
结论:
- GDMT,特别是四重疗法,为患有HFrEF的患者提供了巨大的好处.
- 尽管GDMT已被证明是有效的,但仍未得到充分利用,因此需要进一步努力加强其实施.
- 优化GDMT的使用对于改善HFrEF的长期结果至关重要.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
431
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431
01:22Heart Failure Drugs: Diuretics
381
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
381
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:22Heart Failure Drugs: β-Blockers
340
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
340
01:26Heart Failure Drugs: Inotropic Agents
588
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
588
01:26Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K